Antigen- Specific Immune Tolerance Drug Development Summit

Start Date : April 24, 2018
End Date : April 26, 2018
Time : 8:00 am to5:00 pm

Phone : +6174554188
Email : infohansonwade@gmail.com

Location :
The Aloft Boston Seaport, 401-403 D St, 02210, Boston, MA, United States

Website

Description

As the first generation of antigen-specific immune tolerance therapies enter clinics and with excitement around recent partnerships, IPOs and investments reaching new heights, now is the time for an industry forum for large pharma, pioneering biotech and academia to be able to meet and share knowledge.


 


The 1st Antigen-Specific Immune Tolerance Drug Development Summit is that forum, and has a brand-new agenda that can help you successfully overcome the scientific, product development and commercialization challenges currently being faced.


 


http://as-immunetolerance.com/about/about-event/


 


Brochure https://go.evvnt.com/187943-1?pid=350


 


Prices:


Conference + 2 Workshops Earlybird (Book by 26/01/18): USD 3197


Conference + 2 Workshops (standard rate): USD 3797


Conference + 1 Workshop Earlybird (Book by 26/01/18): USD 2798


Conference + 1 Workshop (standard rate): USD 3398


Conference Earlybird (Book by 26/01/18): USD 2199


Conference (Standard rate): USD 2799


Speakers: Amy S. Rosenberg (CDER/FDA), Arpita Maiti (Pfizer, Inc.), Lachy McLean (Takeda Pharmaceuticals), Jose M. Carballido (Novartis), Jack A. Ragheb (Eli Lilly & Co), Lawrence A. Steinman (Tolerion), Laurence A. Turka (Immune Tolerance Network), Matthias von Herrath (Novo Nordisk), Kei Kishimoto (Selecta Biosciences), Jonathan Zalevsky (Nektar Therapeutics), Francisco J. Quintana (AnTolRx)

Registration Info

Register Now

 

Organized by

Organized by LoveEvvnt1

Hanson Wade


Event Categories: Health & Nutrition.




Your Review

You must be logged in to post a comment.